our Premium Content: News alerts, weekly reports and conference planners

DRUG:

CD33/CLL1 dual CAR-NK cell

News alerts, weekly reports and conference planners

Company:

Qihan Biotech

Drug class:

NK cell stimulant, CD33 inhibitor, CLL-1 inhibitor

Related drugs:

‹

cytotoxic lymphocyte-based cancer vaccine (0)

GCC4001 (0)

CAR-ITNK cells (0)

CAR-NK-CD19 cells (0)

CAR.70/IL15-transduced CB-NK cells (0)

CAR19-CYNK (0)

CB CAR-NK019 (0)

CBT101 (0)

CD123 targeted CAR-NK (0)

CDH17 CAR-NK cell therapy (0)

CHM 2301 (0)

CIML NK (0)

CLDN6-CAR-NK cell therapy (0)

DC vaccine for prostate cancer (0)

primed NK cell therapy (0)

NK/γδ T cell-enriched cell therapy (0)

NK92-CD16-158V (0)

NKG2D CAR-NK cell therapy (0)

NKG2D-CAR-NK92 cells (0)

Super NK cell therapy (0)

TROP2-CAR-NK (0)

UD TGFbetai NK cells (0)

›

over1year

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia (clinicaltrials.gov)

P1, N=102, Not yet recruiting, Institute of Hematology & Blood Diseases Hospital

over 1 year ago

New P1 trial

CD33 (CD33 Molecule)

CD33 positive • CD33 expression

cytarabine • fludarabine IV • CD33/CLL1 dual CAR-NK cell • Super NK cell therapy